Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.
This lecture and workshop series is designed to provide researchers in the life sciences with a comprehensive introduction to the bioscience business environment by exploring the process of transforming a scientific idea into a value-generating product. In addition to developing core business competencies such as financial literacy, strategic partnership building, and business plan development, students will learn to navigate the complexities of intellectual property management, regulatory approval, product development, and reimbursement strategies. Some sessions will also include workshops on networking, negotiation, team-building, and business communication skills. The course will integrate lectures by industry experts with interactive workshops and team-based case studies to provide students with a framework to assess the opportunities and challenges presented by a dynamic biotechnology market.
Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.
MON., SEPT. 19, 5:30-7:30pm: "Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies" with Colleen Cuffaro, Associate at Canaan Partners. Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.
TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.
WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include: Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.
October 19, 5:30-7:30pm: "Case Studies in Life Science Entrepreneurship" with Manon Cox, President & CEO, Protein Sciences Corporation; Arikha Moses, Founder & Senior Executive, Galatea Surgical and Milind Deshpande, President & CEO, Achillion Pharmaceuticals
November 16, 5:30-7:30pm: "Tech Transfer - IP & Licensing" with Leslie-Anne Maxwell, Partner and Pharmaceutical Patent Services Group Leader, Cantor Colburn, Erika Smith, Director of the Blavatnik Fund for Innovation at Yale and David Lewin, Senior Associate Director of Licensing at the Yale Office of Cooperative Research.
December 12, 5:30-7:30pm (Please note Monday!): "Science of Schmoozing -Learning the Keys to Networking" with Scott Nevins, Principal at Bernstein Global Wealth Management and Jim Boyle, Managing Director of the Yale Entrepreneurial Institute. Get ready for the season of networking with expert advice and fun hands-on activities to successfully prepare you to build relationships at your next networking event. Try out your skills at the CURE Holiday Party the following evening!
December 13, 5-7pm: CURE Holiday Party
January 25, 5:30-7:30pm: "Trends in Life Science Funding & Exits, Corporate Strategy & Business Development" with Marcia Dougan-Moore, Vice President, Development Operations at Arvinas and Tim Shannon, General Partner, Canaan Partners.
February 15, 5:30-7:30pm: "Payors & Reimbursement" with Edmund Pezalla, Subject Matter Expert, Aetna; Jennifer Good, President & CEO, Trevi Therapeutics.
April 19, 5:30-7:30pm: "Medical Devices/Diagnostics & Health IT" with Seth Feuerstein, Chief Medical/Innovation Officer, Magellan Health.